Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.
The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...
BaseLaunch, a platform partnering with scientists and entrepreneurs to launch, fund, and build early biotech ventures, ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Experts highlight biotechnology's potential to drive sustainable growth and career opportunities in India's emerging ...
Biomica, a subsidiary of Evogene, and Lishan Biotech have agreed to a worldwide, exclusive licensing deal for a ...
PARIS--(BUSINESS WIRE)--Regulatory News: Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of ...
THE Tanzania Bureau of Standards (TBS) has introduced 74 biotechnology standards to strengthen consumer protection, food safety and industrial quality control in Tanzania. This was stated on Monday in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results